Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports

Схожие документы

• Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
  по: Cohen, Isaac V., et al.
  Опубликовано: (2021)
• Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
  по: Makunts, Tigran, et al.
  Опубликовано: (2020)
• Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis
  по: Makunts, Tigran, et al.
  Опубликовано: (2019)
• Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
  по: Makunts, Tigran, et al.
  Опубликовано: (2019)
• Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
  по: Cohen, Isaac V., et al.
  Опубликовано: (2017)